Malignant Hyperthermia WHO International Programme on Chemical Safety Prävention und Therapie

Prävention und Therapie

die in den Geschäftsprozess integriert werden muss

-- "Not Gainfully Employed": Women on the Iowa Frontier

Mikhail Bakhtin and the Landscape of Psychiatry

1Idee und Begriffsbestimmung15

Malignant Hyperthermia WHO International Programme on Chemical Safety Prävention und TherapieA HISTORY OF MALIGNANT HYPERTHERMIA Malignant hyperthermia (MH) is a hereditary disorder of muscle. Undoubtedly, individuals have possessed this trait since time immemorial. However, because the trait is usually only unmasked in the presence of potent inhalational anaesthetic agents or non depolarizing skeletal muscle relaxants, the existence of malignant hyperthermia was not suspected until we" after the dawn of the modern anaesthetic era. In the